BioMedNewsBreaks – 180 Life Sciences Corp. Announces New Board Appointments
Oct 13, 2020
KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition company (“SPAC”) that previously entered a definitive agreement to acquire 180 Life Sciences, a clinical-stage biotechnology company, recently announced the appointment of Professor Richard Barker, Larry Gold Md., Shoshana Shendelman PhD., and Donald McGovern Jr. to its board of directors, upon completion of the business combination. 180 Life Sciences is led by Dr. James Woody, who previously served as the founding CEO of OncoMed Pharmaceuticals and president and general manager of Roche Bioscience. “I’m pleased to welcome Richard, Larry, Shoshana and Donald to our board of directors,” Dr. Woody said in the press release. “I have known Larry for many years, and I admire his brilliant work in building Somalogic into the premier worldwide protein identification company. Don and I worked on a biotech board together and his vast PWC international experience will be of immense value to 180 Life Sciences. Richard joins, recommended by Sir Marc Feldman, with his broad and skillful experience in science, management and drug development, having served on the Celgene Board. Shoshana joins as the CEO of Applied Therapeutics, an enterprising biotechnology company she founded and has developed into a dynamic organization. Her recent successful experience in the financing arenas will be exceptionally valuable to our team.”
To view the full press release, visit https://ibn.fm/6xGSJ
About 180 Life Sciences Corp.
180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis and inflammation using anti-TNF, with its lead program in phase 2b/3 clinical trials. For more information about the company, visit www.180LifeSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to 180 Life Sciences are available in the company’s newsroom at http://ibn.fm/180
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Searing Elon Musk Film Nears U.S. Release Amid Overseas Concerns
Alex Gibney’s “Musk” will arrive in United States theaters next month. Universal says it remains committed to releasing it overseas but has yet to set dates.
Trump Seeks ‘Made in U.S.A.’ Labels on Beef as Import Rule Angers Ranchers
The Agriculture Department hopes Americans will pay more for U.S. beef, in an attempt to appease ranchers upset over increased, cheaper imports.
World Bank Courts Private Financing Amid Global Debt Burden
The World Bank president, Ajay Banga, has worked to make the development institution a magnet for private capital as donor nations face budget constraints.
Trump Blasts the Fed But Spares Kevin Warsh After Interest Rate Hike
The president blasted the rest of the Fed — and kept up his demand for a cut — but spared Fed Chairman Kevin M. Warsh from the criticism.
Mixed feelings from consumers as electricity discount to be given to NI households
The one-off £63 reduction in electricity bills will be applied from next month.
Warm words on Canada's EU 'associate membership' but no guarantees
There is no certainty that the idea will ever get off the ground, let alone become a blueprint for other countries, writes the BBC's Katya Adler.
Steve Bannon and Bernie Sanders Condemn Tech ‘Oligarchs’ and Demand A.I. Reforms
At an event in Washington, partisanship took a back seat as elected officials, religious leaders, parents and artists called for reining in artificial intelligence.
Barclays workers ask for more money to return to the office
Unite union, which represents 36,000 Barclays staff, calls for a one-off payment to offset increased travel and childcare costs.
Interest rates held but Bank signals rise if energy prices stay high
Rates are held for the sixth time in a row but the Bank of England says high energy prices make a future rise more likely.
Trump’s Latest Threats Loom Over Fed’s Interest Rate Decision
This month, the president threatened to halt a broad swath of trade if interest rates were not cut, a possibility he resurfaced on Wednesday.
Fed Raises Rates in First Major Step by Warsh to Contain Inflation
The Federal Reserve’s first increase to interest rates since July 2023 comes less than two months before the midterm elections.
Global Economy Is Running Out of Wiggle Room
Many countries blunted the most painful effects of the energy shock from the war in Iran. But prices remain elevated and risks are multiplying.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.